GovChime
Notice ID: 8adb6d3eb2e74caf8d09b6244349ca10Special Notice

Drug Discovery and Development consultants for the National Institute on Drug Abuse (NIDA)

Archived on May 25, 2020. Full description on SAM.gov.

Overview

Posted
February 7, 2020
Notice type
Special Notice
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIDA
Last updated
Sep 25, 2026

Identifiers

Solicitation number
75N95020Q00025
Notice ID
8adb6d3eb2e74caf8d09b6244349ca10

Description

2/7/20 Amendment 01 is posted to provide answers to the questions received from interested vendors. All other terms and conditions of the solicitation remain unchanged. 1/24/20 Solicitation is posted. Please see the attachments for more information.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

No documents available.

Lifecycle

Solicitation:75N95020Q00025
  1. Combined Synopsis
  1. Combined SynopsisJan 24, 2020

    Drug Discovery and Development consultants for the National Institute on Drug Abuse (NIDA)

    Notice 37e4228dab594ff285e33e603af94ea9 on SAM.gov

  2. 2×
    Special NoticeCurrentFeb 7, 2020

    Drug Discovery and Development consultants for the National Institute on Drug Abuse (NIDA)

    Notice 8adb6d3eb2e74caf8d09b6244349ca10 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N95020Q00025

Archive Date

May 25, 2020

Office Address

Bethesda, MD, 20892